Your browser doesn't support javascript.
loading
A Phase I study of intravenous PI3K inhibitor copanlisib in Japanese patients with advanced or refractory solid tumors.
Doi, Toshihiko; Fuse, Nozomu; Yoshino, Takayuki; Kojima, Takashi; Bando, Hideaki; Miyamoto, Hideaki; Kaneko, Masato; Osada, Motonobu; Ohtsu, Atsushi.
Affiliation
  • Doi T; National Cancer Center Hospital East, 5-1, Kashiwanoha 6-chome, Kashiwa-shi, Chiba, 277-8577, Japan. tdoi@east.ncc.go.jp.
  • Fuse N; National Cancer Center Hospital East, 5-1, Kashiwanoha 6-chome, Kashiwa-shi, Chiba, 277-8577, Japan.
  • Yoshino T; National Cancer Center Hospital East, 5-1, Kashiwanoha 6-chome, Kashiwa-shi, Chiba, 277-8577, Japan.
  • Kojima T; National Cancer Center Hospital East, 5-1, Kashiwanoha 6-chome, Kashiwa-shi, Chiba, 277-8577, Japan.
  • Bando H; National Cancer Center Hospital East, 5-1, Kashiwanoha 6-chome, Kashiwa-shi, Chiba, 277-8577, Japan.
  • Miyamoto H; Department of Gastroenterology and Hepatology, Kumamoto University, 2-39-1 Kurokami, Chuo Ward, Kumamoto, 860-8555, Japan.
  • Kaneko M; Bayer Yakuhin, Ltd., 2-4-9, Umeda, Kita-ku, Osaka, 530-0001, Japan.
  • Osada M; Bayer Yakuhin, Ltd., 2-4-9, Umeda, Kita-ku, Osaka, 530-0001, Japan.
  • Ohtsu A; National Cancer Center Hospital East, 5-1, Kashiwanoha 6-chome, Kashiwa-shi, Chiba, 277-8577, Japan.
Cancer Chemother Pharmacol ; 79(1): 89-98, 2017 Jan.
Article in En | MEDLINE | ID: mdl-27915408
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrimidines / Quinazolines / Phosphoinositide-3 Kinase Inhibitors / Neoplasms / Antineoplastic Agents Type of study: Clinical_trials Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Cancer Chemother Pharmacol Year: 2017 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrimidines / Quinazolines / Phosphoinositide-3 Kinase Inhibitors / Neoplasms / Antineoplastic Agents Type of study: Clinical_trials Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Cancer Chemother Pharmacol Year: 2017 Document type: Article Affiliation country: Country of publication: